HIN heartware international, inc
Add to My Watchlist 0.00% ! $2.37

92% success in pivotal bridge-to-transplant

  1. pat done
    4,131 Posts.
    clock Created with Sketch.
    15/11/10
    02:20
    Post #: 7473539
    HeartWare International has added a news release to its Investor Relations website.
    Title: HeartWare Achieves Primary Endpoint with 92% Success in Pivotal Bridge-to-Transplant Clinical Trial c, ADVANCE

    Date(s): 14-Nov-2010 9:02 AM
    HIN Price at posting: $2.12 Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS The 10 hot stocks HotCopper users watchlisted in Week 30
right-arrow Created with Sketch.
AII Analyst Buy Rating: Leading the Charge in Securing the Tungsten Supply Chain
right-arrow Created with Sketch.
NEWS Harness the power of Australia’s leading investor community
right-arrow Created with Sketch.
NEWS Mandalay Shareholders Overwhelmingly Approve Transaction with Alkane Resources
right-arrow Created with Sketch.
NEWS LISTEN NOW: HotCopperWire, our market watch podcast!
right-arrow Created with Sketch.
NEWS Access the Latest ASX news daily on HotCopper
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.